Application of CRISPR/Cas9 Technology in Rice Germplasm Innovation and Genetic Improvement
Genes · 2024
DOI: 10.3390/genes15111492 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Jijin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Agrobiological Gene Center, Shanghai 201106, China. Hauptthemen laut MEDLINE: Oryza, CRISPR-Cas Systems, Gene Editing, Plant Breeding. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Commission of Science and technology, The Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Improving the efficiency of germplasm innovation has always been the aim of rice breeders. Traditional hybrid breeding methods for variety selection rarely meet the practical needs of rice production. The emergence of genome-editing technologies, such as CRISPR/Cas9, provides a new approach to the genetic improvement of crops such as rice. The number of published scientific papers related to “gene editing” and “CRISPR/Cas9” retrievable on websites both from China and other countries exhibited an increasing trend, year by year, from 2014 to 2023. Research related to gene editing in rice accounts for 33.4% and 12.3% of all the literature on gene editing published in China and other countries, respectively, much higher than that on maize and wheat. This article reviews recent research on CRISPR/Cas9 gene-editing technology in rice, especially germplasm innovation and genetic improvement of commercially promoted varieties with improved traits such as disease, insect, and herbicide resistance, salt tolerance, quality, nutrition, and safety. The aim is to provide a reference for the precise and efficient development of new rice cultivars that meet market demand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Agrobiological Gene Center, Shanghai 201106, China.
ORCID-Profile: Anning Zhang, Yi Liu
Förderung
- Shanghai Municipal Commission of Science and technology
- The Bill and Melinda Gates Foundation
Zitieren
APA
Chen, J., Miao, Z., Kong, D., Zhang, A., Wang, F., Liu, G., Yu, X., Luo, L., & Liu, Y. (2024). Application of CRISPR/Cas9 Technology in Rice Germplasm Innovation and Genetic Improvement. Genes. https://doi.org/10.3390/genes15111492
Vancouver
Chen J, Miao Z, Kong D, Zhang A, Wang F, Liu G, et al. Application of CRISPR/Cas9 Technology in Rice Germplasm Innovation and Genetic Improvement. Genes. 2024. doi:10.3390/genes15111492
BibTeX
@article{Chen2024,
author = {Chen, Jijin and Miao, Zhening and Kong, Deyan and Zhang, Anning and Wang, Feiming and Liu, Guolan and Yu, Xinqiao and Luo, Lijun and Liu, Yi},
title = {Application of CRISPR/Cas9 Technology in Rice Germplasm Innovation and Genetic Improvement},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15111492}
}
EUVIMED